# Using Complexity and Spectral Analyses of Noninvasive LDF Signals in Patients with Metabolic Syndrome

Authors: Hsin Hsiu; Hsiao-Feng Hu; Yaw-Wen Chang
Journal: Complexity
 (2018)

---

## Abstract

This study performed skin-surface measurements with the aim of verifying if complexity and spectral analyses applied to laser-Doppler-flowmetry (LDF) signals can be used to discriminate control subjects and patients with metabolic syndrome (MetS) and patients with premetabolic syndrome (pre-MetS). The study participants (n
=
142) were assigned to three age-matched groups based on the application of MetS criteria. Beat-to-beat analysis was performed to obtain the mean blood flow (DC), and then approximate entropy (ApEn) values for the 10-minute DC sequences (DC_ApEn) were calculated to evaluate the signal complexity. The wavelet transform was applied and yielded periodic oscillations with five characteristic frequency peaks (defined as FR1–FR5) whose relative energy contributions (RECs) were calculated. DC_ApEn was significantly smaller in MetS and pre-MetS (with one or two Mets factors) patients than in controls, whereas there were no significant differences in DC. The REC of FR1 was significantly smaller while the REC of FR4 was significantly larger in pre-MetS than in MetS. These results indicate the presence of significant differences in ApEn and spectral indexes, which may be partly attributable to changes in microcirculatory regulatory activities accompanying the progression of MetS. The present findings may be pertinent to the early detection of the microcirculatory impairments associated with MetS.


---

## Body

## 1. Introduction

Metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities associated with an increased risk of cardiovascular diseases [1, 2]. MetS is associated with dysfunction of both the macro- and microcirculation, with MetS patients exhibiting both macro- and microvascular impairments [1, 3].Early detection of vascular complications and preventing their progression are important in the management of cardiovascular diseases. At the macrocirculation level, although the pathways linking components of MetS to increased cardiovascular risk remain unknown, various intermediates such as intima-media thickness and arterial stiffness have been proposed [1]. At the microcirculation level, the cutaneous circulation can be considered representative of the microcirculation in most vascular beds [1], and therefore the skin microcirculation has been proposed as a model of systemic microvascular function that could facilitate investigations of the mechanisms underlying cardiovascular diseases [2].Laser-Doppler-flowmetry (LDF) utilizes the Doppler shift of the laser light reflected from the red blood cells and has the advantages of noninvasive and real-time measurement for investigations of microcirculatory-blood-flow (MBF) responses. Other than the MBF supply itself, time-domain indexes of beat-to-beat LDF waveforms are suggested to be able to aid the monitoring of the MBF perfusion condition [4, 5]. Spectral LDF indexes are also used to study the activities of different microcirculatory regulatory mechanisms [6–8]. Nonlinear analysis provides information about the variability structure of skin blood-flow oscillations [9, 10]. For example, complexity analysis (which could reflect the number of interacting mechanisms [9]) of beat-to-beat LDF signals has been used to study the induced MBF response in subjects with certain diseases or following certain external stimulation [9, 11, 12].Among the nonlinear analysis methods, approximate entropy (ApEn) is widely used for evaluating complexity of data sequence [13]. In the present study, we applied beat-to-beat, spectral, and ApEn analyses to skin-surface LDF signals with the aim of discriminating the following three age-matched groups: MetS patients, premetabolic syndrome (pre-MetS) patients, and control subjects. The present findings may be pertinent to the early detection of impairment of MBF perfusion accompanying MetS.


## 2. Methods

### 2.1. Experimental Procedure

The abbreviations used in this study are summarized in “Abbreviations” section. Details of study methods can be referred to previous studies [4, 6, 14]. Measurement was performed on 142 volunteers; details of subjects are listed in Tables 1–3. The study population was recruited at the Health Management Center of Tri-Service General Hospital. The study was reviewed and approved by the institutional review board of Tri-Service General Hospital (TSGHIRB 2-101-05-045). All subjects gave their informed consent before experiments commenced. According to the criteria listed in Table 1, the subjects were assigned into three age-matched groups: Group A (with no less than three MetS factors, MetS); Group B (with one or two MetS factors, pre-MetS); Group C (with no MetS factor, control).Table 1
Number of subjects fulfilled the criteria of metabolic syndrome.
Factor criteria
Number of subjects
MetS
Pre-MetS
Control
(n
=
41)
(n
=
67)
(n
=
34)
Waist circumference ≥ 90 cm (male); ≥0.80 cm (female)
28
32
0
Blood pressure ≥ 140/90 mmHg
30
22
0
High-density lipoprotein cholesterol ≤ 0.9 mmol/L (male), ≤1.0 mmol/L (female)
34
15
0
Fasting plasma glucose ≥ 100 mg/dl
20
5
0
Triglycerides: ≥100 mg/dl
32
7
0Table 2
Number of subjects who have chronic conditions.
Chronic condition
Number of subjects
MetS
Pre-MetS
Control
(n
=
41)
(n
=
67)
(n
=
34)
Diabetes
2
0
0
Cardiovascular disease
0
2
1
Hyperlipidemia
9
2
2
Hypertension
4
0
0
Liver disease
0
13
5
Peptic ulcer Disease
0
4
0
Renal disease
0
0
0
Polycystic ovary syndrome
0
4
1Table 3
Fundamental physiological parameters (quantity or mean ± standard deviation) of subjects.
Parameters
MetS
Pre-MetS
Control
Statistical significance†
(n
=
41)
(n
=
67)
(n
=
34)
Gender (male/female)
27/14
22/45
15/19
Age (years)
44.5 ± 10.6
48.4 ± 12.9
42.7 ± 10.5
Heart rate (beats/minute)
73.3 ± 9.2
73.3 ± 9.5
71.1 ± 8.2
BMI (kg/m2)
26.8 ± 3.5
24.4 ± 3.8
22.3 ± 3.0
AC
Waist circumference (cm)
89.3 ± 8.2
82.9 ± 8.9
79.6 ± 9.1
AC
Systolic blood pressure (mm-Hg)
126.2 ± 12.5
119.8 ± 14.5
106.1 ± 11.3
AC, BC
Diastolic blood pressure (mm-Hg)
85.7 ± 7.5
79.5 ± 10.4
70.4 ± 6.9
AC, BC
HDL-C (mg/dl)
39.8 ± 10.0
57.1 ± 9.5
60.3 ± 13.7
AB, AC
Fasting glucose (mg/dl)
98.4 ± 8.8
90.3 ± 6.5
85.1 ± 5.1
AB, AC
Triglyceride (mg/dl)
237.6 ± 168.1
101.0 ± 42.2
93.2 ± 32.4
AB, AC
†Significant difference between groups (p
<
0.05). A: MetS, B: pre-MetS, and C: control.


### 2.2. Measurements

ECG signals were measured by surface electrodes (lead II, RA-LL) and acquired by a preamplifier (6600, Gould, USA). MBF flux signal was measured by Moor VMS-LDF (VP1 probe; MBF3, Moor Instruments, UK), with a time constant of 0.001 s, a cut-off frequency of 14.9 kHz, and a sampling frequency of 40 Hz (typical waveforms shown in Figure1) [14]. The LDF probe was placed at the right side for the subjects. Subjects were asked to sit on a chair and to relax and breathe naturally throughout the measurement period. The signals were sampled at 1024 Hz.Figure 1
Typical LDF waveforms measured (in arbitrary units) in (a) MetS patients, (b) pre-MetS patients, and (c) control subjects.
(a)
(b)
(c)In each recording, 10 min data sequence was acquired. Before the LDF measurement, the heart rate (HR), systolic blood pressure (BP), and diastolic BP were measured by using a sphygmomanometer (MG150f, Rossmax). The environmental temperature was within 23–25°C during the entire measuring period. The skin-surface temperature (which was monitored by the same LDF probe) stability was considered acceptable when the variation was less than 1.0°C [4, 6].


### 2.3. Data Analysis

Details of study methods can be referred to previous studies [11, 12]. The neighboring minimal points were used to define each pulse. For all the pulses in the 10-minute sequence, average of their mean values was calculated to define the microcirculatory blood flow (DC). Values of the coefficient of variance of DC for all the pulses within a 10-minute LDF data sequence were then calculated (DC_CV).ApEn analysis was then performed on each 10-minute sequence of DC (DC_ApEn) of the beat-to-beat LDF data sequence. For a sequenceu
(
n
), the ApEn (pattern length m
=
2; criterion of similarity r = 0.2 × SD) can be calculated as follows:(1)
A
p
E
n
=
Φ
m
r
-
Φ
m
+
1
r
,where(2)
Φ
m
r
≡
N
-
m
+
1
-
1
∑
i
=
1
N
-
m
+
1
ln
⁡
C
i
m
r
C
i
m
r
=
number  of
x
j
such  that
d
x
i
,
x
j
≤
r
/
N
-
m
+
1
x
i
=
u
i
,
…
,
u
i
+
m
-
1
,
x
j
=
u
j
,
…
,
u
j
+
m
-
1
,where N is number of pulses in the beat-to-beat LDF data sequence and d represents difference between elements [13, 15].In the LDF spectrum of human subjects, periodic oscillations with five characteristic frequency peaks falling within the following frequency bands can be noted: 0.0095–0.02, 0.02–0.06, 0.06–0.15, 0.15–0.4, and 0.4–1.6 Hz (defined as FR1-FR5, resp.). The relative energy contribution (REC) was defined as the ratio between the total energy density within each band and the entire 0.0095-to-1.6 Hz spectrum [6].


### 2.4. Statistics

All statistical analyses were carried out using SPSS, version 13.0. The differences in the fundamental physiological and LDF parameters were assessed using the Kruskal–Wallis test (nonparametric ANOVA). Post hoc multiple comparisons tests were made by Dunn’s test. The level of significance was defined asp
<
0.05; all p values were two-sided hypotheses.


## 2.1. Experimental Procedure

The abbreviations used in this study are summarized in “Abbreviations” section. Details of study methods can be referred to previous studies [4, 6, 14]. Measurement was performed on 142 volunteers; details of subjects are listed in Tables 1–3. The study population was recruited at the Health Management Center of Tri-Service General Hospital. The study was reviewed and approved by the institutional review board of Tri-Service General Hospital (TSGHIRB 2-101-05-045). All subjects gave their informed consent before experiments commenced. According to the criteria listed in Table 1, the subjects were assigned into three age-matched groups: Group A (with no less than three MetS factors, MetS); Group B (with one or two MetS factors, pre-MetS); Group C (with no MetS factor, control).Table 1
Number of subjects fulfilled the criteria of metabolic syndrome.
Factor criteria
Number of subjects
MetS
Pre-MetS
Control
(n
=
41)
(n
=
67)
(n
=
34)
Waist circumference ≥ 90 cm (male); ≥0.80 cm (female)
28
32
0
Blood pressure ≥ 140/90 mmHg
30
22
0
High-density lipoprotein cholesterol ≤ 0.9 mmol/L (male), ≤1.0 mmol/L (female)
34
15
0
Fasting plasma glucose ≥ 100 mg/dl
20
5
0
Triglycerides: ≥100 mg/dl
32
7
0Table 2
Number of subjects who have chronic conditions.
Chronic condition
Number of subjects
MetS
Pre-MetS
Control
(n
=
41)
(n
=
67)
(n
=
34)
Diabetes
2
0
0
Cardiovascular disease
0
2
1
Hyperlipidemia
9
2
2
Hypertension
4
0
0
Liver disease
0
13
5
Peptic ulcer Disease
0
4
0
Renal disease
0
0
0
Polycystic ovary syndrome
0
4
1Table 3
Fundamental physiological parameters (quantity or mean ± standard deviation) of subjects.
Parameters
MetS
Pre-MetS
Control
Statistical significance†
(n
=
41)
(n
=
67)
(n
=
34)
Gender (male/female)
27/14
22/45
15/19
Age (years)
44.5 ± 10.6
48.4 ± 12.9
42.7 ± 10.5
Heart rate (beats/minute)
73.3 ± 9.2
73.3 ± 9.5
71.1 ± 8.2
BMI (kg/m2)
26.8 ± 3.5
24.4 ± 3.8
22.3 ± 3.0
AC
Waist circumference (cm)
89.3 ± 8.2
82.9 ± 8.9
79.6 ± 9.1
AC
Systolic blood pressure (mm-Hg)
126.2 ± 12.5
119.8 ± 14.5
106.1 ± 11.3
AC, BC
Diastolic blood pressure (mm-Hg)
85.7 ± 7.5
79.5 ± 10.4
70.4 ± 6.9
AC, BC
HDL-C (mg/dl)
39.8 ± 10.0
57.1 ± 9.5
60.3 ± 13.7
AB, AC
Fasting glucose (mg/dl)
98.4 ± 8.8
90.3 ± 6.5
85.1 ± 5.1
AB, AC
Triglyceride (mg/dl)
237.6 ± 168.1
101.0 ± 42.2
93.2 ± 32.4
AB, AC
†Significant difference between groups (p
<
0.05). A: MetS, B: pre-MetS, and C: control.


## 2.2. Measurements

ECG signals were measured by surface electrodes (lead II, RA-LL) and acquired by a preamplifier (6600, Gould, USA). MBF flux signal was measured by Moor VMS-LDF (VP1 probe; MBF3, Moor Instruments, UK), with a time constant of 0.001 s, a cut-off frequency of 14.9 kHz, and a sampling frequency of 40 Hz (typical waveforms shown in Figure1) [14]. The LDF probe was placed at the right side for the subjects. Subjects were asked to sit on a chair and to relax and breathe naturally throughout the measurement period. The signals were sampled at 1024 Hz.Figure 1
Typical LDF waveforms measured (in arbitrary units) in (a) MetS patients, (b) pre-MetS patients, and (c) control subjects.
(a)
(b)
(c)In each recording, 10 min data sequence was acquired. Before the LDF measurement, the heart rate (HR), systolic blood pressure (BP), and diastolic BP were measured by using a sphygmomanometer (MG150f, Rossmax). The environmental temperature was within 23–25°C during the entire measuring period. The skin-surface temperature (which was monitored by the same LDF probe) stability was considered acceptable when the variation was less than 1.0°C [4, 6].


## 2.3. Data Analysis

Details of study methods can be referred to previous studies [11, 12]. The neighboring minimal points were used to define each pulse. For all the pulses in the 10-minute sequence, average of their mean values was calculated to define the microcirculatory blood flow (DC). Values of the coefficient of variance of DC for all the pulses within a 10-minute LDF data sequence were then calculated (DC_CV).ApEn analysis was then performed on each 10-minute sequence of DC (DC_ApEn) of the beat-to-beat LDF data sequence. For a sequenceu
(
n
), the ApEn (pattern length m
=
2; criterion of similarity r = 0.2 × SD) can be calculated as follows:(1)
A
p
E
n
=
Φ
m
r
-
Φ
m
+
1
r
,where(2)
Φ
m
r
≡
N
-
m
+
1
-
1
∑
i
=
1
N
-
m
+
1
ln
⁡
C
i
m
r
C
i
m
r
=
number  of
x
j
such  that
d
x
i
,
x
j
≤
r
/
N
-
m
+
1
x
i
=
u
i
,
…
,
u
i
+
m
-
1
,
x
j
=
u
j
,
…
,
u
j
+
m
-
1
,where N is number of pulses in the beat-to-beat LDF data sequence and d represents difference between elements [13, 15].In the LDF spectrum of human subjects, periodic oscillations with five characteristic frequency peaks falling within the following frequency bands can be noted: 0.0095–0.02, 0.02–0.06, 0.06–0.15, 0.15–0.4, and 0.4–1.6 Hz (defined as FR1-FR5, resp.). The relative energy contribution (REC) was defined as the ratio between the total energy density within each band and the entire 0.0095-to-1.6 Hz spectrum [6].


## 2.4. Statistics

All statistical analyses were carried out using SPSS, version 13.0. The differences in the fundamental physiological and LDF parameters were assessed using the Kruskal–Wallis test (nonparametric ANOVA). Post hoc multiple comparisons tests were made by Dunn’s test. The level of significance was defined asp
<
0.05; all p values were two-sided hypotheses.


## 3. Results

Details of the included subjects are given in Tables1 and 2, and the basic physiological parameters in all groups are listed in Table 3. There were no significant differences in age and HR among the three groups, whereas all of the measured physiological parameters were significantly larger in MetS group than in control group, with the exception of HDL-C (which was smaller).The comparison of LDF beat-to-beat parameters in Figure2 reveals that DC_ApEn was significantly smaller in Groups A and B than in control group. There were no significant differences in DC or DC_CV.Figure 2
Comparison of LDF beat-to-beat parameters (mean ± SD). “” indicates p
<
0.05. DC_ApEn was significantly smaller in Groups A and B than in control group. There were no significant differences in DC or DC_CV. The circles indicate far values and “∗” indicates far out values.The comparison of LDF spectral parameters in Figure3 reveals that the REC of FR1 was significantly smaller while the RECs of FR4 and FR5 were significantly larger in Group B than in Group A. There was no significant difference in the REC of any band between Groups A and C.Figure 3
Comparison of LDF spectral parameters (mean ± SD). “” indicates p
<
0.05. The REC of FR1 was significant smaller while the RECs of FR4 and FR5 were significantly larger in Group B than in Group A. There were no significant differences between Groups A and C. The circles indicate far values and “∗” indicates far out values.


## 4. Discussion

At the macrovascular level, MetS has been characterized by morphological and functional disorders within large vessels [2]. For example, increases in both the peripheral and central blood pressure, pulse wave velocity, and arterial stiffness have been noted in patients with MetS [1]. At the microvascular level, endothelium-dependent dysfunction of the microcirculation has been reported in patients with MetS without hypertension [2]. MetS patients have also been noted to have a lower density of functional capillaries [3]. Several possible underlying mechanisms have been proposed; for example, a higher skin microcirculation resistance (possibly induced by lower cutaneous vascular conductance response to ACh and SNP iontophoresis) has implications for the NO pathway, and a decreased production of anti-inflammatory adipokines has been reported in MetS patients [2, 3].


### 4.1. ApEn Index

This study found that DC_ApEn was significantly smaller in Groups A and B than in Group C. A marked reduction in the blood flow associated with both endothelial-derived and direct vasodilatory mechanisms has been noted in MetS [3]. In terms of dynamic responses, generalized vasoreactivity impairment has been demonstrated in patients with MetS, even in the absence of type-2 diabetes [2]. Skin microvascular abnormalities in response to ischemia have been observed in MetS patients [16]. It is possible that such a defect in the peripheral blood flow supply reduces the microcirculatory regulatory activity. The number of participating regulatory mechanisms may be decreased or the degrees of freedom of the regulatory activities may be reduced due to an impaired MBF supply. These factors may decrease the complexity in the skin-surface LDF signals and thus decrease the ApEn value. Furthermore, there was a progressive increase in the ApEn values in Groups A–C. This illustrates that the presence of decreased complexity in the skin-surface LDF beat-to-beat index may accompany the progression of MetS.


### 4.2. DCCV

Beat-to-beat cardiovascular variability parameters such as HR variability and BP variability are widely used to monitor cardiovascular regulatory activity. Similarly, variability indexes for the MBF supply might also be suitable for monitoring the microcirculatory regulatory activities in local vascular beds. Changes in MBF variability parameters have been suggested to be related to the adjustment effort of the cardiovascular system when it is stimulated in different ways [17, 18]. Significant differences in MBF variability parameters have been found between normal control subjects and patients with various types of diseases, including stroke and diabetes [4, 5]. However, the present study found no significant intergroup differences in DCCV, which illustrates that the ApEn index is better than the DCCV index for distinguishing between the present MetS patients and control subjects. A possible explanation for this difference is DCCV being related to the extent that MBF perfusion varies in the presence of microcirculatory regulation, whereas DC_ApEn could reflect the complexity in the MBF fluctuation patterns of MetS patients under changes in certain specific types of microcirculatory regulatory activity; for example, it is possible that DC_ApEn is affected more by the local microcirculatory regulatory activities that change the elastic or morphological properties of the local vascular beds.


### 4.3. Spectral Indices

LDF spectral analysis has been widely used in studies of the microcirculatory regulatory activities in local vascular beds [6, 7]. Calculating LDF spectral indexes may help to further identify the possible changes in the microcirculatory regulatory activities in MetS patients. The present study found significant differences in the RECs of several frequency bands of the LDF signals; for example, the REC of FR1 was significantly smaller in Group pre-MetS than in Group MetS. The vascular endothelium plays a key role in the pathogenesis of microangiopathy and neuropathy by producing compounds such as nitric oxide, endothelin, and prostacyclin [3]. Endothelium-dependent dysfunction of the microcirculation has been reported in patients with MetS without hypertension [2]. It has been suggested that changes in the REC of FR1 are associated with endothelial regulatory functions in the microcirculation [7]. The differences in REC of FR1 noted between Groups MetS and pre-MetS could be at least partly attributable to endothelial function being more severely impaired in the former group. An impaired endothelial function may decrease the amount and types of vasoactive agents secreted, reduce the degrees of freedom for local microcirculatory endothelial regulation, and decrease the complexity in MBF fluctuations, thereby leading to decreases in the ApEn value in Group MetS.The REC of FR4 was significantly smaller in Group MetS than in Group pre-MetS. It has been suggested that changes in the REC of FR4 are associated with baroreflex regulatory functions in the microcirculation [7]. Both SBP and DBP were significantly smaller in control group than in the other groups. It is possible that, during the early stage of MetS progression, the baroreflex regulatory functions can be activated to compensate the effects of an increased BP. This could have resulted in the REC of FR4 being slightly larger (although nonsignificantly) in Group pre-MetS than in Group control. The induced effect of the increase in BP could have lasted longer and been larger in Group MetS than in Group pre-MetS. There could be a gradual reduction in the ability of the baroreflex to adjust the BP value, hence resulting in the REC of FR4 being significantly smaller in Group MetS than in Group pre-MetS. This could partly account for the difference in the changes in the REC of FR4 between Groups MetS and pre-MetS.


### 4.4. Discussion in the Present Indices

The present results for ApEn values may help to differentiate control subjects from patients with MetS and pre-MetS, while those for spectral indexes may help to differentiate between MetS and pre-MetS patients. Changes in the ApEn values precede those in the beat-to-beat LDF indexes themselves, and so the present findings may be pertinent to the early detection of the impairment of MBF perfusion associated with MetS.Few previous studies have focused on the effects on the complexity in MBF perfusion accompanying MetS. However, the effect of aging has been widely discussed. For example, it has been reported that the complexity in MBF is significantly lower among those aged 75–85 years than those aged 65–75 years [10], which can be partly attributed to vascular impairment associated with aging. This means that the mechanism underlying the decreased ApEn value in the present Group MetS (e.g., vascular impairment) may be similar to vascular aging effects. Another study found that increased complexity in the skin-surface LDF beat-to-beat index paralleled the disease progression of diabetes. Impairment of the MBF perfusion condition in diabetic patients (perhaps due to impaired endothelial function caused by hyperglycemia, oxidative stress, and dyslipidemia) may result in further impairment of the ability to maintain homeostasis of the MBF supply, which may in turn have led to the increases in complexity and ApEn values measured in the present diabetic patients [19]. It is possible that, compared with diabetic patients, such impairment in the MBF perfusion condition had not yet occurred in the MetS patients, which is also supported by the absence of significant differences in DC values between the present groups. The change in the ability to maintain homeostasis of the MBF supply was less severe in MetS patients, and hence the change in the complexity in the MBF signals differed between MetS and diabetic patients.


## 4.1. ApEn Index

This study found that DC_ApEn was significantly smaller in Groups A and B than in Group C. A marked reduction in the blood flow associated with both endothelial-derived and direct vasodilatory mechanisms has been noted in MetS [3]. In terms of dynamic responses, generalized vasoreactivity impairment has been demonstrated in patients with MetS, even in the absence of type-2 diabetes [2]. Skin microvascular abnormalities in response to ischemia have been observed in MetS patients [16]. It is possible that such a defect in the peripheral blood flow supply reduces the microcirculatory regulatory activity. The number of participating regulatory mechanisms may be decreased or the degrees of freedom of the regulatory activities may be reduced due to an impaired MBF supply. These factors may decrease the complexity in the skin-surface LDF signals and thus decrease the ApEn value. Furthermore, there was a progressive increase in the ApEn values in Groups A–C. This illustrates that the presence of decreased complexity in the skin-surface LDF beat-to-beat index may accompany the progression of MetS.


## 4.2. DCCV

Beat-to-beat cardiovascular variability parameters such as HR variability and BP variability are widely used to monitor cardiovascular regulatory activity. Similarly, variability indexes for the MBF supply might also be suitable for monitoring the microcirculatory regulatory activities in local vascular beds. Changes in MBF variability parameters have been suggested to be related to the adjustment effort of the cardiovascular system when it is stimulated in different ways [17, 18]. Significant differences in MBF variability parameters have been found between normal control subjects and patients with various types of diseases, including stroke and diabetes [4, 5]. However, the present study found no significant intergroup differences in DCCV, which illustrates that the ApEn index is better than the DCCV index for distinguishing between the present MetS patients and control subjects. A possible explanation for this difference is DCCV being related to the extent that MBF perfusion varies in the presence of microcirculatory regulation, whereas DC_ApEn could reflect the complexity in the MBF fluctuation patterns of MetS patients under changes in certain specific types of microcirculatory regulatory activity; for example, it is possible that DC_ApEn is affected more by the local microcirculatory regulatory activities that change the elastic or morphological properties of the local vascular beds.


## 4.3. Spectral Indices

LDF spectral analysis has been widely used in studies of the microcirculatory regulatory activities in local vascular beds [6, 7]. Calculating LDF spectral indexes may help to further identify the possible changes in the microcirculatory regulatory activities in MetS patients. The present study found significant differences in the RECs of several frequency bands of the LDF signals; for example, the REC of FR1 was significantly smaller in Group pre-MetS than in Group MetS. The vascular endothelium plays a key role in the pathogenesis of microangiopathy and neuropathy by producing compounds such as nitric oxide, endothelin, and prostacyclin [3]. Endothelium-dependent dysfunction of the microcirculation has been reported in patients with MetS without hypertension [2]. It has been suggested that changes in the REC of FR1 are associated with endothelial regulatory functions in the microcirculation [7]. The differences in REC of FR1 noted between Groups MetS and pre-MetS could be at least partly attributable to endothelial function being more severely impaired in the former group. An impaired endothelial function may decrease the amount and types of vasoactive agents secreted, reduce the degrees of freedom for local microcirculatory endothelial regulation, and decrease the complexity in MBF fluctuations, thereby leading to decreases in the ApEn value in Group MetS.The REC of FR4 was significantly smaller in Group MetS than in Group pre-MetS. It has been suggested that changes in the REC of FR4 are associated with baroreflex regulatory functions in the microcirculation [7]. Both SBP and DBP were significantly smaller in control group than in the other groups. It is possible that, during the early stage of MetS progression, the baroreflex regulatory functions can be activated to compensate the effects of an increased BP. This could have resulted in the REC of FR4 being slightly larger (although nonsignificantly) in Group pre-MetS than in Group control. The induced effect of the increase in BP could have lasted longer and been larger in Group MetS than in Group pre-MetS. There could be a gradual reduction in the ability of the baroreflex to adjust the BP value, hence resulting in the REC of FR4 being significantly smaller in Group MetS than in Group pre-MetS. This could partly account for the difference in the changes in the REC of FR4 between Groups MetS and pre-MetS.


## 4.4. Discussion in the Present Indices

The present results for ApEn values may help to differentiate control subjects from patients with MetS and pre-MetS, while those for spectral indexes may help to differentiate between MetS and pre-MetS patients. Changes in the ApEn values precede those in the beat-to-beat LDF indexes themselves, and so the present findings may be pertinent to the early detection of the impairment of MBF perfusion associated with MetS.Few previous studies have focused on the effects on the complexity in MBF perfusion accompanying MetS. However, the effect of aging has been widely discussed. For example, it has been reported that the complexity in MBF is significantly lower among those aged 75–85 years than those aged 65–75 years [10], which can be partly attributed to vascular impairment associated with aging. This means that the mechanism underlying the decreased ApEn value in the present Group MetS (e.g., vascular impairment) may be similar to vascular aging effects. Another study found that increased complexity in the skin-surface LDF beat-to-beat index paralleled the disease progression of diabetes. Impairment of the MBF perfusion condition in diabetic patients (perhaps due to impaired endothelial function caused by hyperglycemia, oxidative stress, and dyslipidemia) may result in further impairment of the ability to maintain homeostasis of the MBF supply, which may in turn have led to the increases in complexity and ApEn values measured in the present diabetic patients [19]. It is possible that, compared with diabetic patients, such impairment in the MBF perfusion condition had not yet occurred in the MetS patients, which is also supported by the absence of significant differences in DC values between the present groups. The change in the ability to maintain homeostasis of the MBF supply was less severe in MetS patients, and hence the change in the complexity in the MBF signals differed between MetS and diabetic patients.


## 5. Conclusion

The following conclusions can be drawn from the results obtained in this study.(i)
The presence of decreased complexity in the beat-to-beat LDF index sequence may be at least partly attributable to changes in the microcirculatory regulatory activities or impairment of the homeostasis mechanism of MBF perfusion.
(ii)
The spectral analysis of the LDF signals revealed that the differences in the ApEn values could be related to the changes in the endothelial function and baroreflex activity accompanying the progression of MetS.



---

*Source: 6898024-2018-02-25.xml*